Tagged With GILD Stock Price

Gilead tanks 9% on report its coronavirus drug doesn't help patients


One Wall Street firm says approval for Gilead's experimental coronavirus treatment is a coin-flip bet at best — but still thinks you should buy the stock right now


A small group of scientists, execs, and VCs are $277 million richer as their companies race to create a coronavirus vaccine. Here are 7 who have raked in huge sums.



Drug developer Gilead soars to 16-month high after WHO official says its experimental treatment is best shot for fighting coronavirus